Exercise recommendations and risk factors for sudden cardiac death

Pediatric Clinics of North America

Volumn 51, Issue 5, 2004, Pages 1401-1420

  Cava, Joseph R ^a   Danduran, Michael J ^b   Fedderly, Raymond T ^a   Sayger, Pamela L ^a,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^c Division of Pediatric Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; ATHLETE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DYNAMIC EXERCISE; DYSPNEA; FALLOT TETRALOGY; FAMILY HISTORY; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; LONG QT SYNDROME; MARFAN SYNDROME; MEDICAL DECISION MAKING; MITRAL VALVE PROLAPSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; OBESITY; PHYSICAL EXAMINATION; PREDICTION; PREVALENCE; PULMONARY ARTERY; QRS COMPLEX; REVIEW; RISK FACTOR; SPORT; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL TECHNIQUE; SYNCOPE; THORAX PAIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; WOLFF PARKINSON WHITE SYNDROME;

ADOLESCENT; ARRHYTHMIA; CHILD; CORONARY VESSEL ANOMALIES; DEATH, SUDDEN, CARDIAC; EXERCISE; EXERCISE TEST; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION; MEDICAL HISTORY TAKING; OBESITY; PHYSICAL EXAMINATION; RISK FACTORS; SPORTS;

EID: 4344593438     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.04.004     Document Type: Review

References (55)

1. Maron B., Mitchell J. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;846-899
2. Mitchell J.H., Maron B.J., Epstein S.E. 16th Bethesda Conference. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. J Am Coll Cardiol. 6(6):1985;1189-1190
3. Berger S., Dhala A., Friedberg D. Sudden cardiac death in infants, children, and adolescents. Ped Clin North Am. 46(2):1999;221-234
4. Gilette P.C., Garson A. Jr. Sudden cardiac death in the pediatric patient. Circulation. 85(1 Suppl):1992;164-169
5. Vetter V.L. Sudden death in infants, children, and adolescents. Cardiovasc Clin. 15(3):1985;301-313
6. Tanji J. The preparticipation physical examination for sports. American Family Practice. 42(2):1990;397-402
7. Maron B.J., Thompson P.D., Puffer J.C., McGrew C.A., Strong W.B., Douglas P.S., et al. Cardiovascular preparticipation screening of competitive athletes. Circulation. 94:1996;850-856
8. Glover D., Maron B.J. Profile of preparticipation cardiovascular screening for high school athletes. JAMA. 279(22):1998;1817-1820
9. Maron B.J., Gohman T., Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardio. 32(7):1998;1881-1884
10. Liberthson R.R. Sudden death from cardiac causes in children and young adults. N Engl J Med. 334(16):1996;1039-1044
11. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.O. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 276(3):1996;199-204
12. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 92(4):1995;785-789
13. Maron B.J., Bonow R., Cannon R., Leon M., Epstein S. Hypertrophic cardiomyopathy. N Engl J Med. 316(14):1987;780-852
14. McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 47:1981;532-538
15. Ostman-Smith I., Wettrell G., Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy. J Am Coll Cardio. 34(6):1999;1813-1822
16. Frescura C., Basso C., Thiene G., Corrado D., Pennelli T., Angelini A., et al. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol. 29:1998;689-695
17. Donaldson R.M., Raphael M., Yacoub M.H., Ross D.N. Hemodynamically significant anomalies of the coronary arteries: surgical aspects. Thorac Cardiovasc Surg. 30:1982;7-13
18. Frommelt P., Frommelt M., Tweddell J., Jaquiss R. Prospective echo diagnosis and surgical repair of anomalous origin of a coronary artery (AOCA) from the opposite sinus with an interarterial course. J Am Coll Cardiol. 42:2003;148-154
19. Menke D.M., Waller B.F., Pless J. Hypoplastic coronary arteries and high take-off position of the right coronary ostium, a fatal combination of congenital coronary artery anomalies in an amateur athlete. Chest. 88:1985;299-301
20. Weidenbener E., Krauss M., Waller B., Taliercio C. Incorporation of screening echocardiography in the preparticipation exam. Clin J Sport Med. 5(2):1995;86-89
21. Lewis J.F., Maron B.J., Diggs J.A., Spencer J.E., Mehrotra P.P., Curry C.L. Preparticipation echocardiographic screening for cardiovascular disease in a large, predominately black population of collegiate athletes. Am J Cardiol. 64:1989;1029-1033
22. Murray P.M., Cantwell J.D., Heith D.L., Shoop J. The role of limited echocardiography in screening athletes. Am J Cardiol. 76:1995;849-850
23. Maron B.J., Bodison S., Wesley Y., Tucker E., Green K. Results of screening large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 10(6):1987;1214-1221
24. LaCorte M., Boxer R., Gottesfeld I., Singh S., Strong M., Mandell L. EKG screening program for school athletes. Clin Cardiol. 12:1989;42-44
25. Huston T., Puffer J., Rodney W. The athlete's heart syndrome. N Engl J Med. 313(1):1985;24-32
26. Maron B., Pelliccia A., Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 91(5):1995;1596-1601
27. Sharma S., Maron B.J., Whyte G., Firoozi S., Elliott P., McKenna W. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol. 40(8):2002;1431-1436
28. Pelliccia A., Paolo F.M., Maron B.J. The athlete's heart: remodeling, electrocardiogram, and preparticipation screening. Cardiol Rev. 10(2):2002;85-90
29. Dipchand A., McCrindle B., Gow R., Freedom R., Hamilton R. Accuracy of surface electrocardiograms for differentiating children with hypertrophic cardiomyopathy from normal children. Am J Cardiol. 83:1999;628-630
30. Frommelt P., Friedberg D., Frommelt M., Williamson J. Anomalous origin of the right coronary from the left sinus of valsalva: transthoracic echocardiographic diagnosis. J Am Soc Echocardiogr. 12(3):1999;221-224
31. Frommelt P., Berger S., Pelech A., Bergstrom S., Williamson J. Prospective identification of anomalous origin of left coronary artery from the right sinus of valsalva using transthoracic echocardiography: importance of color Doppler flow mapping. Pediatr Cardiol. 22(4):2001;327-332
32. Sallourm J.A., Thomas D., Evans J. Transesophageal echocardiography in diagnosis of aberrant coronary artery. Int J Cardiol. 32:1991;106-107
33. Zehender M., Meinertz T., Keul J., Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J. 119(6):1990;1378-1391
34. Oakley C. The electrocardiogram in the highly trained athlete. Cardiol Clin. 10(2):1992;295-302
35. Risser W., Hoffman H., Bellah G., Green L. A cost-benefit analysis of preparticipation sports examinations of adolescent athletes. J Sch Health. 55(7):1985;270-273
36. Bar-Or O. Exercise in pediatric assessment and diagnosis. Scand J Sport Sci. 7:1985;35-39
37. American College of Sports Medicine Guidelines for exercise testing and prescription. 4th edition:1991;Lea & Febiger, Philadelphia
38. Washington R., Bricker T., Alpert B., Daniels S., Deckelbaum R., Fisher E., et al. Guidelines for exercise testing in the pediatric age group. AHA Council on CVDY. Circulation. 90(4):1994;2166-2179
39. Mitchell J., Haskell W., Raven P. Classification of sports in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;864-866
40. American Academy of Pediatrics. Committee on Sports Medicine and Fitness Medical conditions affecting sports participation. Pediatrics. 107(5):2001;1205-1209
41. Graham T., Bricker J., James F., Strong W. Task force 1: congenital heart disease in 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;867-873
42. Cheitlin M., Douglas P., Parmley W. Task force 2: acquired valvular heart disease in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;874-880
43. Maron B., Isner J., McKenna W. Task force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial disease and mitral valve prolapse in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;880-885
44. Kaplan N., Deveraux R., Miller H. Task force 4: systemic hypertension in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;885-888
45. Thompson P., Klocke F., Levine B., Camp S. Task force 5: coronary artery disease in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;888-892
46. Zipes D., Garson A. Task force 6: arrhythmias in the 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 24(4):1994;892-899
47. Munger T., Packer D., Hammill S., Feldman B., Bailey K., Ballard D., et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmstead County, Minnesota. Circulation. 87(3):1993;866-873
48. Ackerman M.J. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc. 73(3):1998;250-269
49. Playford D., Weyman A.E. Mitral valve prolapse: time for a fresh look. Rev Cardiovasc Med. 2(2):2001;73-81
50. Devereux R.B. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol. 10(2):1995;107-116
51. National High Blood Pressure Education Program Working on Hypertension Control in Children and Adolescents Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics. 98(4):1996;649-658
52. Task Force on Blood Pressure Control in Children Report of the second task force on blood pressure control in children. Pediatrics. 79(1):1987;1-25
53. Barlow S.E., Dietz W.H. Obesity evaluation and treatment: expert committee recommendations. Pediatrics. 102(3):1998;1-11
54. Dietz W.H. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 101:1998;518-525
55. Bar-Or O. Obesity. Goldberg B. Sports and exercise for children with chronic heart conditions. 1995;335-353 Human Kinetics Publishers, Inc., Champaign (IL)